JP2023530983A5 - - Google Patents

Info

Publication number
JP2023530983A5
JP2023530983A5 JP2022577444A JP2022577444A JP2023530983A5 JP 2023530983 A5 JP2023530983 A5 JP 2023530983A5 JP 2022577444 A JP2022577444 A JP 2022577444A JP 2022577444 A JP2022577444 A JP 2022577444A JP 2023530983 A5 JP2023530983 A5 JP 2023530983A5
Authority
JP
Japan
Application number
JP2022577444A
Other languages
Japanese (ja)
Other versions
JP2023530983A (ja
JPWO2021255459A5 (https=
Filing date
Publication date
Priority claimed from GBGB2009224.3A external-priority patent/GB202009224D0/en
Priority claimed from GBGB2107412.5A external-priority patent/GB202107412D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/051536 external-priority patent/WO2021255459A1/en
Publication of JP2023530983A publication Critical patent/JP2023530983A/ja
Publication of JPWO2021255459A5 publication Critical patent/JPWO2021255459A5/ja
Publication of JP2023530983A5 publication Critical patent/JP2023530983A5/ja
Pending legal-status Critical Current

Links

JP2022577444A 2020-06-17 2021-06-17 がんおよび/またはcin3を検出および予測するための方法 Pending JP2023530983A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2009224.3A GB202009224D0 (en) 2020-06-17 2020-06-17 Methods for detecting and predicting cancer and/or cin3
GB2009224.3 2020-06-17
GBGB2107412.5A GB202107412D0 (en) 2021-05-25 2021-05-25 Methods for detecting and predicting cancer and/or CIN3
GB2107412.5 2021-05-25
PCT/GB2021/051536 WO2021255459A1 (en) 2020-06-17 2021-06-17 Methods for detecting and predicting cancer and/or cin3

Publications (3)

Publication Number Publication Date
JP2023530983A JP2023530983A (ja) 2023-07-20
JPWO2021255459A5 JPWO2021255459A5 (https=) 2024-06-20
JP2023530983A5 true JP2023530983A5 (https=) 2024-06-20

Family

ID=76730905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022577444A Pending JP2023530983A (ja) 2020-06-17 2021-06-17 がんおよび/またはcin3を検出および予測するための方法

Country Status (10)

Country Link
US (1) US20240191302A1 (https=)
EP (1) EP4168587A1 (https=)
JP (1) JP2023530983A (https=)
KR (1) KR20230024344A (https=)
AU (1) AU2021291133A1 (https=)
BR (1) BR112022025789A2 (https=)
CA (1) CA3186997A1 (https=)
IL (1) IL299142A (https=)
MX (1) MX2022016100A (https=)
WO (1) WO2021255459A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202315787D0 (en) * 2023-10-16 2023-11-29 Sola Diagnostics Gmbh Method
GB202401477D0 (en) * 2024-02-05 2024-03-20 Sola Diagnostics Gmbh Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013033627A2 (en) * 2011-09-01 2013-03-07 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
WO2016041010A1 (en) * 2014-09-15 2016-03-24 Garvan Institute Of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
US9984201B2 (en) * 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
JP7299158B2 (ja) * 2017-03-10 2023-06-27 セルフ-スクリーン ベー.フェー. Hpv誘発浸潤がん、非hpv誘発婦人科がん及び肛門性器がん、並びにその高度前駆病変を検出するためのメチル化分類子
US12480164B2 (en) * 2018-12-04 2025-11-25 EpiMedTechGlobal (EMTG) DNA methylation biomarkers for early detection of cervical cancer

Similar Documents

Publication Publication Date Title
JP2023530983A5 (https=)
CN305695508S (https=)
CN305532071S (https=)
CN305536848S (https=)
CN305536810S (https=)
CN305534370S (https=)
CN305533467S (https=)
CN305531938S (https=)
CN305531768S (https=)
CN305531935S (https=)
CN305528827S (https=)
CN305527298S (https=)
CN306913182S (https=)
CN305531599S (https=)
CN306364569S (https=)
CN306363282S (https=)
CN306161631S (https=)
CN305528860S (https=)
CN306160359S (https=)
CN306088086S (https=)
CN306085621S (https=)
CN306085098S (https=)
CN306083737S (https=)
CN306070749S (https=)
CN306070340S (https=)